Variant report
Variant | nsv821891 |
---|---|
Chromosome Location | chr2:210255831-210256291 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:210251892..210254829-chr2:210256212..210260046,3 | MCF-7 | breast: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs10194421 | chr2:210255863-210255864 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs188518630 | chr2:210255910-210255911 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs540669220 | chr2:210255916-210255917 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs530185945 | chr2:210255944-210255945 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs531154186 | chr2:210255956-210255957 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs533047870 | chr2:210255980-210255981 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs549869882 | chr2:210255989-210255990 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs527367776 | chr2:210255990-210255991 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs569768104 | chr2:210256061-210256062 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs548426893 | chr2:210256073-210256074 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs181362083 | chr2:210256111-210256112 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs76137394 | chr2:210256112-210256113 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs11676811 | chr2:210256157-210256158 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
14 | rs11457175 | chr2:210256160-210256161 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs397772984 | chr2:210256166-210256167 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs1446588 | chr2:210256170-210256171 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
17 | rs141278792 | chr2:210256194-210256195 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs553863247 | chr2:210256234-210256235 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs570791353 | chr2:210256243-210256244 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cervical cancer | 21062161 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Autism | 20808228 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Ovarian cancer | 19193619 | CNVD |
Non-small cell lung cancer | 18676828 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Chordoma | 18071362 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 18923514 | CNVD |
Schizophrenia | 22241247 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Developmental delay | 21147756 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:210248800-210256000 | Weak transcription | NHLF | lung |
2 | chr2:210254000-210256600 | Weak transcription | Placenta Amnion | Placenta Amnion |
3 | chr2:210254400-210258400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
4 | chr2:210254800-210256000 | Weak transcription | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
5 | chr2:210255400-210257200 | Enhancers | Liver | Liver |
6 | chr2:210255600-210256400 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
7 | chr2:210256000-210256200 | Enhancers | NHLF | lung |
8 | chr2:210256000-210258000 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
9 | chr2:210256000-210258400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
10 | chr2:210256200-210256600 | Weak transcription | NHLF | lung |